Skip to main content
. 2023 Dec 18;10:2291–2303. doi: 10.2147/JHC.S437415

Table 2.

Results of the Univariate and Multivariate Analysis in the Primary Cohort

Variable (Reference) Univariate Analysis Multivariate Analysis
OR(95% CI) P value OR(95% CI) P value
Age 1.01 (0.99,1.03) 0.418
Gender (male) 1.28 (0.58,2.85) 0.543
Lesion size 0.92 (0.86,0.98) 0.015* 1.02 (0.94,1.12) 0.563
Lesion number (1)
 >1 0.62 (0.23,1.64) 0.333
Liver cirrhosis
(negative)
1.03 (0.64,1.67) 0.902
CEA (<5 ug/L) 1.20 (0.52,2.79) 0.670
AFP (<400 ug/L) 1.10 (0.67,1.83) 0.699
HBsAg (negative) 1.06 (0.53,2.13) 0.859
WBC (<10*10^9/L) 0.74 (0.16,3.39) 0.703
NE% (<0.75) 1.21 (0.36,4.06) 0.759
PLT (<100*10^9/L) 0.56 (0.24,1.26) 0.160
PT (<14s) 1.72 (0.61,4.88) 0.307
TBIL (<22 umol/L) 1.06 (0.53,2.13) 0.859
DBIL (<7 umol/L) 1.11 (0.45,2.71) 0.820
ALB (<35 g/L) 0.86 (0.40,1.84) 0.699
ALT (<40 U/L) 1.00 (0.61,1.64) 1.000
AST (<37 U/L) 0.86 (0.53,1.39) 0.539
ALP (<110 U/L) 0.68 (0.37,1.26) 0.218
GGT (<50 U/L) 0.83 (0.51,1.35) 0.461
BCLC stage (0 stage)
 A 0.46 (0.09,2.41) 0.355
 B 0.33 (0.04,2.52) 0.288
 C 0.29 (0.05,1.57) 0.150
Rad-score 2.72 (2.11,3.49) <0.001* 2.76 (2.17,3.65) <0.001*

Notes: *p values below 0.05 (indicated with asterisk) were considered significant statistically in univariate and multivariate analysis.